XBiotech Inc.
XBIT
$8.55
-$0.06-0.70%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | 300.00K | 1.98M | 3.51M | 4.01M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 300.00K | 1.98M | 3.51M | 4.01M |
| Cost of Revenue | -- | 16.00K | 231.00K | 438.00K | 651.00K |
| Gross Profit | -- | 284.00K | 1.75M | 3.07M | 3.36M |
| SG&A Expenses | 4.66M | 5.01M | 4.88M | 5.91M | 6.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.51M | 37.39M | 36.93M | 37.30M | 38.50M |
| Operating Income | -37.51M | -37.09M | -34.95M | -33.79M | -34.49M |
| Income Before Tax | -24.31M | -22.21M | -25.41M | -30.99M | -33.59M |
| Income Tax Expenses | 243.00K | 920.00K | 3.01M | 334.00K | -688.00K |
| Earnings from Continuing Operations | -24.56 | -23.13 | -28.42 | -31.32 | -32.90 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.56M | -23.13M | -28.42M | -31.32M | -32.90M |
| EBIT | -37.51M | -37.09M | -34.95M | -33.79M | -34.49M |
| EBITDA | -35.77M | -35.33M | -32.90M | -31.44M | -31.88M |
| EPS Basic | -0.81 | -0.76 | -0.93 | -1.03 | -1.08 |
| Normalized Basic EPS | -0.50 | -0.46 | -0.52 | -0.64 | -0.69 |
| EPS Diluted | -0.81 | -0.76 | -0.93 | -1.03 | -1.08 |
| Normalized Diluted EPS | -0.50 | -0.46 | -0.52 | -0.64 | -0.69 |
| Average Basic Shares Outstanding | 121.76M | 121.75M | 121.76M | 121.76M | 121.76M |
| Average Diluted Shares Outstanding | 121.76M | 121.75M | 121.76M | 121.76M | 121.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
